We are scientists! As National Institutes of Health funded researchers, we have devoted our lives to research. From the synthesis of active molecules to the formulation of elegant formulas, we use cutting edge science to make products that help you look, feel, and age better.
In our world, science and technology rule. Through our research, we’ve not only discovered intelligent, multifunctional ingredients and formulas, but we’ve also created proprietary intelligent delivery systems.
Co-Founder & CEO | Dr. Isaacman is co-founder and CEO of PHD Skin Care, Visiting Scholar at New York University, and Director of Research at Nanometics- a New York City based biotechnology company that develops therapeutics for breast cancer, sickle cell disease, and skin cancer prevention. A well respected authority in skin and sun care, Dr. Isaacman co-authors a quarterly column for Cosmetics and Toiletries magazine with his brother Steven. Dr. Isaacman is an expert in skin cancer prevention, and leads a National Cancer Institute funded project that aims to develop long-wear sunscreens for skin cancer prevention. He received his BS in biology from the State University of New York at Albany, and his Ph.D. in polymer chemistry from the University of California, Santa Barbara where his research focused on the design of silicone-based polymers for drug delivery and personal care. Michael has published in the ﬁelds of skin care, natural product synthesis, pollutant sensors, and polymer chemistry.
Co-Founder & CEO | Dr. Isaacman is co-founder of PHD Skin Care, Visiting Scholar at New York University, Visiting Scientist at the Albert Einstein College of Medicine, and CEO at PHD Biosciences - a New York City based biotechnology company that develops therapeutics for breast cancer, sickle cell disease, and skin cancer prevention. Dr. Isaacman has been involved in the skin care industry for over 14 years and has invented several products that are used globally in skin care. A well respected authority in skin and sun care, he co-authors a quarterly column for Cosmetics and Toiletries magazine with his brother Michael. As a National Institutes of Health funded researcher, Dr. Isaacman is one of the few industrial scientists funded by the National Cancer Institute. At PHD Biosciences, he leads a team of clinical and basic science researchers in the pursuit of treatments for diseases with high unmet medical need. Dr. Isaacman received his BS in biochemistry and MS in organic chemistry from Stony Brook University, and his Ph.D. in physical organic chemistry from New York University where his research involved the design of materials for quantum computers, and imaging agents for the early detection of cancer.
Drs. Steven and Michael Isaacman lead a diverse research team that is developing a new treatment for breast cancer. The project has gained signiﬁcant community support and is funded by the National Cancer Institute, Avon Foundation for Women, University of Buﬀalo and Stony Brook University. Learn more about the project, and how you can join the ﬁght against breast cancer.www.phdbiosciences.com